MRSH Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

179.810

Open

177.810

VWAP

177.91

Vol

1.83M

Mkt Cap

85.76B

Low

175.910

Amount

325.75M

EV/EBITDA(TTM)

13.27

Total Shares

481.79M

103.41B

EV/OCF(TTM)

19.79

P/S(TTM)

3.12

Marsh & McLennan Companies, Inc. is a professional services company in the areas of risk, reinsurance and capital, people and investments, and management consulting. The Company conducts business through two segments: Risk and Insurance Services, and Consulting. It conducts business in this segment through Marsh Risk and Guy Carpenter. Marsh Risk is an insurance broker and risk advisor offering risk management, insurance broking, insurance program management, risk consulting, analytical modeling and alternative risk financing services to a range of businesses, government entities, and individuals. Guy Carpenter is a reinsurance intermediary and advisor providing specialized reinsurance broking, strategic advisory and actuarial services. The consulting segment includes health, wealth and career advice, solutions and products, and specialized management, strategic, economic and brand consulting services. It conducts business in this segment through Mercer and Marsh Management Consulting.

Events Timeline

(ET)

2026-05-04

09:20:00

Oliver Wyman Acquires CR3 Partners

2026-04-30 (ET)

2026-04-30

09:10:00

Marsh McLennan to Acquire TriBridge Partners

2026-04-28 (ET)

2026-04-28

07:50:00

Marsh Announces Multi-Year Partnership with Formula 1

News

7.5

06-29CNBC

Extreme Weather's Impact on Data Centers

7.5

06-29Newsfilter

Extreme Weather Pressures AI Data Centers

9.5

06-23Newsfilter

Marsh to Announce Q2 Financial Results on July 21, 2026

6.5

06-01CNBC

Investors Should Focus on Dividend Stocks Amid Market Volatility

8.5

06-01Newsfilter

Marsh McLennan Agency Completes Acquisition of TriBridge Partners

5.0

06-01Newsfilter

Oliver Wyman Appoints New General Counsel

0 Analyst Rating

Wall Street analysts forecast MRSH stock price to rise

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

Morgan Stanley

Equal Weight

maintain

$180 -> $175

AI Analysis

2026-07-06

New

Reason

Morgan Stanley

Price Target

$180 -> $175

AI Analysis

2026-07-06

New

maintain

Equal Weight

Reason

Morgan Stanley lowered the firm's price target on Marsh McLennan to $175 from $180 and keeps an Equal Weight rating on the shares. Heading into earnings, property and casualty insurance trends remain broadly unchanged, with solid underwriting supported by low catastrophe losses and moderating inflation offsetting continued pricing softening, though the recent valuation rebound creates a more challenging near-term setup, the analyst tells investors in a research note.

Piper Sandler

Paul Newsome

Neutral

downgrade

$190 -> $182

2026-05-26

Reason

Piper Sandler

Paul Newsome

Price Target

$190 -> $182

2026-05-26

downgrade

Neutral

Reason

Piper Sandler analyst Paul Newsome lowered the firm's price target on Marsh McLennan to $182 from $190 and keeps a Neutral rating on the shares. The firm cites recent stock performance and the roll-forward of time. In general, Piper has slightly raised price targets for most of the insurance carriers and reduced price targets for some of the insurance brokers. Its analysis tends to be bottom-up in its approach and following first quarter results, the firm thinks it is probably wise to focus on the carriers over the insurance brokers since underwriting performance in general was a better help than expected for the carriers and organic growth results for the broker.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MRSH

Unlock Now

Valuation Metrics

The current forward P/E ratio for Marsh & McLennan Companies Inc (MRSH.N) is 16.89, compared to its 5-year average forward P/E of 16.63. For a more detailed relative valuation and DCF analysis to assess Marsh & McLennan Companies Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

16.63

Current PE

16.89

Overvalued PE

17.40

Undervalued PE

15.87

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

12.70

Current EV/EBITDA

13.12

Overvalued EV/EBITDA

13.22

Undervalued EV/EBITDA

12.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

2.81

Current PS

2.90

Overvalued PS

2.96

Undervalued PS

2.67

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

high dividend growth stock

Intellectia · 26 candidates

Market Cap: >= 10.00BDividend Yield Ttm: 2 - 6Eps 5yr Cagr: >= 5Dividend Payout Ratio: 20.00 - 70.00Dividend 5yr Cagr: >= 8

Ticker

Name

Market Cap$

Morgan Stanley

268.01B

NEE

Nextera Energy Inc

199.35B

NVO

Novo Nordisk A/S

172.30B

Toronto-Dominion Bank

159.44B

ACN

Accenture PLC

129.99B

BMO

Bank of Montreal

100.88B

Whales Holding MRSH

Polar Capital Holdings Plc

Polar Asset Management Partners Inc.

Baker Avenue Asset Management, LP

Raiffeisen Kapitalanlage-Gesellschaft m.b.H.

Assenagon Asset Management S.A.

Susquehanna Fundamental Investments, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Marsh & McLennan Companies Inc (MRSH) stock price today?

The current price of MRSH is 178 USD — it has increased 1.87

What is Marsh & McLennan Companies Inc (MRSH)'s business?

What is the price predicton of MRSH Stock?

Wall Street analysts forecast MRSH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MRSH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.